XML 41 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Payments (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]    
Stock-Based Compensation Expenses $ 35.0 $ 35.0
Common Shares Available for Grant 18,000,000  
Aggregate Maximum of Common Shares 20,000,000  
Stock Options And SARs    
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]    
Stock-based compensation expense related to stock options, SAR and ESPP grants $ 8.0 $ 10.0
Unrecognized compensation expense $ 54.0  
Weighted average period over which unrecognized compensation expense will be recognized (in years) 1 year 10 months 24 days  
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]    
Weighted Average Fair Value of Grants (price per share) $ 28.30 $ 17.03
Expected Volatility (in hundredths) 42.20% 47.18%
Risk-Free Interest Rate (in hundredths) 0.89% 0.28%
Dividend Yield (in hundredths) 3.28% 3.25%
Expected Life (in years) 5 years 3 months 18 days 5 years 2 months 12 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]    
Outstanding at January 1 (in shares) 9,969,000 10,186,000
Granted (in shares) 2,000 7,000
Exercised (1) (in shares) [1] (2,324,000) (26,000)
Forfeited (in shares) (81,000) (103,000)
Outstanding at March 31 (2) [2] 7,566,000 10,064,000
Stock Options and SARs Vested or Expected to Vest (3) (in shares) [3] 7,256,000 9,749,000
Stock Options and SARs Exercisable at March 31 (4) (in shares) [4] 3,886,000 6,288,000
Intrinsic Value of Stock Options/SARs Exercised [1] $ 62.0 $ 0.2
Intrinsic Value of Stock Options/SARs Outstanding [2] $ 277.0 $ 71.0
Weighted Average Remaining Contractual Life for Stock Options/SARs Outstanding (in years) [2] 4 years 3 months 18 days 4 years
Intrinsic Value of Stock Options/SARs Vested or Expected to Vest [3] $ 260.0 $ 66.0
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years) [3] 4 years 3 months 18 days 4 years
Aggregate Intrinsic Value for Exercisable Units [4] $ 82.0 $ 3.0
Weighted average remaining contractual life for exercisable options/SARs (in years) [4] 2 years 10 months 24 days 3 years
Weighted Average Grant Price Stock Option and SARs [Rollforward]    
Outstanding at January 1 (price per share) $ 84.37 $ 84.08
Granted (price per share) 97.64 53.98
Exercised (1) (price per share) [1] 84.63 63.25
Forfeited (price per share) 85.86 89.21
Outstanding at March 31 (2) (price per share) [2] 84.28 84.06
Vested or Expected to Vest (3) (price per share) [3] 85.05 84.74
Exercisable at March 31 (4) (price per share) [4] 101.26 96.47
ESPP    
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]    
Weighted Average Fair Value of Grants (price per share) $ 23.07 $ 14.69
Expected Volatility (in hundredths) 39.72% 54.99%
Risk-Free Interest Rate (in hundredths) 0.22% 0.09%
Dividend Yield (in hundredths) 3.32% 3.41%
Expected Life (in years) 6 months 6 months
Restricted Stock And Restricted Stock Units    
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]    
Unrecognized compensation expense $ 172.0  
Weighted average period over which unrecognized compensation expense will be recognized (in years) 1 year 6 months  
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost $ 25.0 $ 24.0
Restricted Stock/Restricted Stock Units and Performance Units [Roll Forward]    
Outstanding at January 1 (in shares) 4,680,000 4,742,000
Granted (in shares) 14,000 12,000
Released (2) (in shares) [5] (699,000) (430,000)
Forfeited for Performance Multiple (3) (in shares) (51,000) (25,000)
Outstanding at March 31 (4) [6] 3,944,000 4,299,000
Intrinsic value released during the year [5] $ 81.0 $ 31.0
Aggregate intrinsic value of stock and units outstanding [6] $ 470.0 $ 312.0
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward]    
Outstanding at January 1 (price per share) $ 69.37 $ 74.97
Granted (price per share) 110.66 60.27
Released (2) (price per share) [5] 93.37 90.27
Forfeited (price per share) 66.77 71.16
Outstanding at March 31 (3) (price per share) [6] $ 65.30 $ 73.42
Performance Unit    
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]    
Stock-Based Compensation Expenses $ 2.0 $ 1.0
Unrecognized compensation expense $ 11.0  
Weighted average period over which unrecognized compensation expense will be recognized (in years) 1 year 10 months 24 days  
Restricted Stock/Restricted Stock Units and Performance Units [Roll Forward]    
Outstanding at January 1 (in shares) 679,000 613,000
Granted (in shares) 0 8,000
Granted for Performance Multiple (1) (in shares) [7] 0 19,000
Released (2) (in shares) [8] (57,000) (98,000)
Forfeited for Performance Multiple (3) (in shares) [9] (56,000) 0
Outstanding at March 31 (4) [10] 566,000 [11] 542,000
Intrinsic value released during the year [8] $ 7.0 $ 6.0
Aggregate intrinsic value of stock and units outstanding [10] $ 67.0 $ 39.0
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward]    
Outstanding at January 1 (price per share) $ 84.97 $ 88.38
Granted (price per share) 0 49.86
Granted for Performance Multiple (1) (in dollars per share) [7] 0 96.29
Released (2) (price per share) [8] 136.74 96.29
Forfeited (price per share) [9] 136.74 0
Outstanding at March 31 (3) (price per share) [10] $ 74.60 $ 76.18
Performance Units and Performance Stock Disclosures [Abstract]    
Performance Period for Performance Units and Shares 3 years  
Minimum Performance Multiple at the Completion of the Performance Period 0.00%  
Maximum Performance Multiple at the Completion of the Performance Period 200.00%  
Performance Multiple Applied at the Completion Period 50.00% [9] 125.00% [7]
Minimum Performance Units and Stock Allowed to be Outstanding (in shares) [11] 0  
Maximum Performance Units Allowed to be Outstanding (in shares) [11] 1,132  
Lease and Well    
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]    
Stock-Based Compensation Expenses $ 13.0 $ 14.0
Gathering and Processing Costs    
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]    
Stock-Based Compensation Expenses 1.0 0.0
Exploration Costs    
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]    
Stock-Based Compensation Expenses 5.0 6.0
General and Administrative    
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]    
Stock-Based Compensation Expenses $ 16.0 $ 15.0
[1] The total intrinsic value of stock options/SARs exercised during the three months ended March 31, 2022 and 2021 was $62 million and $0.2 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the exercise price of the stock options/SARs.
[2] The total intrinsic value of stock options/SARs outstanding at March 31, 2022 and 2021 was $277 million and $71 million, respectively. At March 31, 2022 and 2021, the weighted average remaining contractual life was 4.3 years and 4.0 years, respectively.
[3] The total intrinsic value of stock options/SARs vested or expected to vest at March 31, 2022 and 2021 was $260 million and $66 million, respectively. At March 31, 2022 and 2021, the weighted average remaining contractual life was 4.3 years and 4.0 years, respectively.
[4] The total intrinsic value of stock options/SARs exercisable at March 31, 2022 and 2021 was $82 million and $3 million, respectively. At March 31, 2022 and 2021, the weighted average remaining contractual life was 2.9 years and 3.0 years, respectively.
[5] The total intrinsic value of restricted stock and restricted stock units released during the three months ended March 31, 2022 and 2021 was $81 million and $31 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released.
[6] The total intrinsic value of restricted stock and restricted stock units outstanding at March 31, 2022 and 2021 was $470 million and $312 million, respectively.
[7] Upon completion of the Performance Period for the Performance Units granted in 2017, a performance multiple of 125% was applied to the grants resulting in an additional grant of Performance Units in February 2021.
[8] The total intrinsic value of Performance Units released was $7 million and $6 million for the three months ended March 31, 2022 and 2021, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the Performance Units are released.
[9] Upon completion of the Performance Period for the Performance Units granted in 2018, a performance multiple of 50% was applied to the grants resulting in a forfeiture of Performance Units in February 2022.
[10] The total intrinsic value of Performance Units outstanding at March 31, 2022 and 2021 was approximately $67 million and $39 million, respectively.
[11] Upon the application of the relevant performance multiple at the completion of each of the remaining Performance Periods, a minimum of zero and a maximum of 1,132 Performance Units could be outstanding.